Versor Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
+87,640
New +$1.05M 2.5% 20
2026
Q1
Sell
-18,529
Closed -$133K 414
2025
Q4
$133K Sell
18,529
-10,000
-35% -$79K 0.02% 578
2025
Q3
$305K Buy
+28,529
New +$280K 0.06% 485
2025
Q1
Sell
-41,226
Closed -$615K 889
2024
Q4
$615K Sell
41,226
-5,800
-12% -$94.5K 0.11% 304
2024
Q3
$900K Buy
47,026
+15,026
+47% +$311K 0.14% 229
2024
Q2
$662K Buy
+32,000
New +$636K 0.12% 264
2023
Q2
Sell
-9,900
Closed -$233K 773
2023
Q1
$233K Sell
9,900
-25,200
-72% -$677K 0.03% 588
2022
Q4
$980K Sell
35,100
-47,781
-58% -$1.22M 0.08% 151
2022
Q3
$1.94M Buy
+82,881
New +$2.5M 0.12% 92
2022
Q1
Sell
-10,537
Closed -$321K 676
2021
Q4
$321K Buy
+10,537
New +$343K 0.01% 384

Other funds holding OGN

Versor Investments's OGN Position: Q2 2026 in Review

Versor Investments opened a new position in Organon & Co (OGN) in Q2 2026: 87,640 shares worth $1.19M. The stake represents 2.5% of the portfolio and ranks #20 among its holdings. This is a return to the name: Versor Investments previously reported a position in OGN as recently as Q4 2025.

Versor Investments first reported a position in OGN in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.94M in Q3 2022. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Versor Investments held 87,640 shares of Organon & Co worth $1.19M as of Q2 2026.
  • Organon & Co was a new Versor Investments position in Q2 2026.
  • Organon & Co made up 2.5% of Versor Investments's portfolio in Q2 2026, its #20 holding.
  • Versor Investments first reported a position in Organon & Co in Q4 2021 and has held it in 10 quarters since.
  • Versor Investments's Organon & Co position peaked at $1.94M in Q3 2022.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Versor Investments's 13F filing for Q2 2026, filed 7 Aug 2026.